FDA Drug recall D-1377-2012
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Ma…
- FDA Drug
- Class II
- terminated
- Published 2012-06-20
On 2012-06-20 the FDA classified a Class II recall of Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Ma… by Ben Venue Laboratories, citing short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1377-2012 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-05-01 |
| Published | 2012-06-20 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Ben Venue Laboratories |
| Distribution | US |
Product
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.
Reason
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Identifiers
| upc | 355390160101 |
|---|---|
| code_info | Lot # 2006500, Exp 08/31/12 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1377-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.